Kirr Marbach Partners Value Fund (KMVAX) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kirr Marbach Partners Value Fund (KMVAX) trades at $38.89 with AI Score 44/100 (Grade C). Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm focused on investing in common stocks across various… Market cap: $116M, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for KMVAX: KMVAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KMVAX against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
KMVAX: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Kirr Marbach Partners Value Fund (KMVAX) Financial Services Profile
Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm that invests in common stocks across small, medium, and large-capitalization companies, seeking to maximize returns through strategic asset allocation. The fund maintains a diversified portfolio with at least 65% of its assets in equity securities, operating within the competitive financial services sector.
What Is the Investment Thesis for KMVAX?
Kirr Marbach Partners Value Fund (KMVAX) presents a notable research candidate due to its diversified investment approach and focus on value investing. The fund's strategy of allocating assets across small, medium, and large-cap companies allows it to capture growth opportunities across various market segments. With at least 65% of its assets invested in equity securities, KMVAX is positioned to benefit from potential market appreciation. However, the fund's performance is subject to market volatility and economic conditions. The fund's beta of 1.08 indicates that it is slightly more volatile than the market. The absence of a dividend yield may deter income-seeking investors. The fund's success hinges on its ability to identify and capitalize on undervalued investment opportunities, while effectively managing risk.
Based on FMP financials and quantitative analysis
KMVAX Key Highlights
Market capitalization of $116M indicates a relatively small fund within the asset management industry.
- Beta of 1.08 suggests the fund's volatility is slightly higher than the overall market.
- Investment strategy focuses on common stocks of companies with small, medium, and large market capitalizations.
- At least 65% of total assets are allocated to common stocks or other equity securities, emphasizing equity-focused investment.
- Absence of dividend yield may be a drawback for income-focused investors.
Who Are KMVAX's Competitors?
KMVAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AABPX American Beacon Balanced Fund | $12.44 | -0.48% | $108M | 38 |
| DDDAX 13D Activist Fund | $26.12 | +0.31% | $116M | 44 |
| EAERX Eaton Vance Stock Fund | $23.50 | -0.72% | $103M | 47 |
| GPRIX Grandeur Peak Global Reach Fund | $15.37 | -0.39% | $85.2M | 44 |
| IHD Voya Emerging Markets High Dividend Equity Fund | $7.49 | +0.67% | $139M | 50 |
| TPZ Tortoise Electrification Infrastructure ETF | $21.62 | -0.18% | $127M | 70 |
| CHECU Chenghe Acquisition III Co. Units | $10.25 | +0.39% | $134M | 67 |
| ETHT ProShares - Ultra Ether ETF | $12.57 | +19.94% | $92.2M | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KMVAX's Key Strengths?
Diversified investment approach across market capitalizations.
- Experienced investment team with a focus on value investing.
- Disciplined investment process with rigorous research and due diligence.
- Commitment to long-term capital appreciation.
What Are KMVAX's Weaknesses?
Relatively small market capitalization compared to larger asset managers.
- Absence of dividend yield may deter income-seeking investors.
- Performance is subject to market volatility and economic conditions.
- High beta compared to benchmark.
What Could Drive KMVAX Stock Higher?
Potential for increased investor inflows due to strong market performance in equity markets.
- Strategic asset allocation across diverse market capitalizations to capture growth opportunities.
- Focus on value investing to identify undervalued companies with long-term potential.
What Are the Key Risks for KMVAX?
Market volatility and economic downturns could negatively impact fund performance.
- Increased competition from other asset management firms could lead to lower fees and margins.
- Regulatory changes and compliance requirements could increase operating costs.
- Dependence on the investment team's ability to identify and capitalize on attractive investment opportunities.
What Are the Growth Opportunities for KMVAX?
- Expansion into new asset classes: KMVAX could explore opportunities to expand its investment offerings into alternative asset classes such as private equity, real estate, or infrastructure. These asset classes can provide diversification benefits and potentially higher returns, attracting a broader range of investors. Timeline: 2-3 years.
- Enhancing digital marketing and investor relations: KMVAX can leverage digital marketing channels and enhance its investor relations efforts to attract new investors and retain existing clients. By improving its online presence and providing transparent communication, KMVAX can build trust and credibility with investors. The digital asset management market is expected to grow at a CAGR of 20% over the next five years, highlighting the importance of digital engagement. Timeline: 1 year.
- Strategic partnerships and acquisitions: KMVAX could pursue strategic partnerships or acquisitions to expand its market reach and enhance its investment capabilities. By collaborating with other asset management firms or acquiring complementary businesses, KMVAX can gain access to new markets, technologies, and talent. The asset management industry is undergoing consolidation, creating opportunities for strategic alliances and acquisitions. Timeline: 3-5 years.
- Focus on sustainable and responsible investing: KMVAX can capitalize on the growing demand for sustainable and responsible investing by incorporating environmental, social, and governance (ESG) factors into its investment process. By offering ESG-focused investment products, KMVAX can attract socially conscious investors and align its investment strategy with global sustainability trends. Timeline: 2 years.
- Developing customized investment solutions: KMVAX can differentiate itself by offering customized investment solutions tailored to the specific needs and objectives of individual investors. By providing personalized investment advice and portfolio management services, KMVAX can build stronger relationships with clients and attract high-net-worth individuals. The demand for customized investment solutions is increasing as investors seek more control and flexibility over their portfolios. Timeline: Ongoing.
What Are KMVAX's Competitive Advantages?
- Experienced investment team with a proven track record.
- Disciplined investment process focused on value investing.
- Diversified portfolio across market capitalizations and sectors.
What Does KMVAX Do?
Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm dedicated to delivering value through strategic investments in common stocks. The fund's primary objective is to achieve long-term capital appreciation by investing in companies across the market capitalization spectrum, including small-cap (less than $1 billion), mid-cap ($1-$15 billion), and large-cap (more than $15 billion) enterprises. The fund operates under the principle of diversification, ensuring that at least 65% of its total assets are allocated to common stocks or other equity securities. KMVAX's investment strategy involves a rigorous analysis of potential investments, focusing on companies with strong fundamentals and growth potential. The fund's portfolio construction process emphasizes a balance between risk and return, aiming to generate consistent performance over time. The fund's investment decisions are guided by a team of experienced professionals who conduct in-depth research and due diligence to identify attractive investment opportunities. KMVAX competes within the broader asset management industry, facing competition from other mutual funds, hedge funds, and investment advisory firms. The fund differentiates itself through its focus on value investing and its commitment to a diversified portfolio. As of 2026, Kirr Marbach Partners Value Fund manages approximately $0.11 billion in assets.
What Products and Services Does KMVAX Offer?
- Invests in common stocks of companies with small-capitalizations (less than $1 billion).
- Invests in common stocks of companies with medium-capitalizations ($1-$15 billion).
- Invests in common stocks of companies with large-capitalizations (more than $15 billion).
- Allocates at least 65% of its total assets to common stocks or other equity securities.
- Seeks long-term capital appreciation through strategic asset allocation.
- Conducts in-depth research and due diligence to identify attractive investment opportunities.
- Manages a diversified portfolio to balance risk and return.
How Does KMVAX Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- AUM is influenced by investment performance and investor inflows/outflows.
- Expenses include investment management fees, administrative costs, and marketing expenses.
What Industry Does KMVAX Operate In?
Kirr Marbach Partners Value Fund (KMVAX) operates within the asset management industry, a sector characterized by intense competition and evolving market dynamics. The industry is influenced by factors such as interest rates, economic growth, and investor sentiment. Asset management firms compete for investor capital by offering a range of investment products and services, including mutual funds, exchange-traded funds (ETFs), and separately managed accounts. The industry is subject to regulatory oversight and compliance requirements, which can impact profitability and growth. KMVAX competes with firms like AABPX, DDDAX, EAERX, GPRIX, and IHD, each vying for market share and investor assets.
Who Are KMVAX's Key Customers?
- Individual investors seeking long-term capital appreciation.
- Institutional investors, including pension funds, endowments, and foundations.
- Financial advisors and wealth managers seeking investment solutions for their clients.
Kirr Marbach Partners Value Fund (KMVAX) Valuation Context
Relative to its peer group, KMVAX's quantitative score of 44/100 is roughly in line with the peer average of 45/100.
KMVAX Financials
Bull Case vs Bear Case
Bull Case
- Diversified investment approach across market capitalizations.
- Experienced investment team with a focus on value investing.
- Disciplined investment process with rigorous research and due diligence.
- Commitment to long-term capital appreciation.
Bear Case
- Relatively small market capitalization compared to larger asset managers.
- Absence of dividend yield may deter income-seeking investors.
- Performance is subject to market volatility and economic conditions.
- High beta compared to benchmark.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
KMVAX Latest News
No recent news available for KMVAX.
KMVAX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KMVAX.
Price Targets
Wall Street price target analysis for KMVAX.
KMVAX MoonshotScore
What does this score mean?
The MoonshotScore rates KMVAX 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
What Investors Ask About Kirr Marbach Partners Value Fund (KMVAX) — Financial Services
What does the AI Score mean for KMVAX?
KMVAX holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm focused on investing in common stocks across various market capitalizations. The fund aims to achieve its investment objective …
What does Kirr Marbach Partners Value Fund do?
Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm that invests in common stocks across various market capitalizations, including small-cap (less than $1 billion), mid-cap ($1-$15 billion), and large-cap (more than $15 billion) companies. The fund's primary objective is to achieve long-term capital appreciation by strategically allocating its assets to companies with strong fundamentals and growth potential.
What are the main risks for KMVAX?
The main risks for Kirr Marbach Partners Value Fund (KMVAX) include market volatility, which can significantly impact the fund's performance, especially given its focus on equity securities. Economic downturns and rising interest rates could also negatively affect the value of the fund's investments. Additionally, increased competition from other asset management firms could lead to lower fees and margins.
What is Kirr Marbach Partners Value Fund's credit quality and risk management approach?
As Kirr Marbach Partners Value Fund primarily invests in common stocks, credit quality is not a direct concern in the same way it would be for a fixed-income fund. However, the fund's risk management approach involves diversification across market capitalizations and sectors to mitigate potential losses from individual stock holdings.
What regulatory challenges does Kirr Marbach Partners Value Fund face?
Kirr Marbach Partners Value Fund operates within a highly regulated environment, subject to oversight by the Securities and Exchange Commission (SEC) and other regulatory bodies. The fund must comply with various regulations, including the Investment Company Act of 1940 and the Dodd-Frank Act, which govern fund operations, disclosure requirements, and investor protection.
What are the key factors to evaluate for KMVAX?
Kirr Marbach Partners Value Fund (KMVAX) holds an AI score of 44/100 (low). Kirr Marbach Partners Value Fund (KMVAX) presents a notable research candidate due to its diversified investment approach and focus on value investing. Not financial advice.
How frequently does KMVAX data refresh on this page?
KMVAX's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven KMVAX's recent stock price performance?
Kirr Marbach Partners Value Fund (KMVAX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified investment approach across market capitalizations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KMVAX overvalued or undervalued right now?
Kirr Marbach Partners Value Fund (KMVAX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for KMVAX, limiting the depth of financial insights.
- Information is based on available data as of 2026-03-18.